Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 1 |
2004 | 1 |
2012 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
The match between adhesive mixture powder formulations for inhalation and the inhaler device.
Eur J Pharm Sci. 2023 Jul 1;186:106457. doi: 10.1016/j.ejps.2023.106457. Epub 2023 Apr 26.
Eur J Pharm Sci. 2023.
PMID: 37116546
Free article.
To address this question, three budesonide-containing reservoir DPIs: Novopulmon Novolizer, Giona Easyhaler and DuoResp Spiromax, were analyzed using the Next Generation Impactor, NGI. ...The Easyhaler, which has a straight mouthpiece outlet, produced an FPF of 18%. When t …
To address this question, three budesonide-containing reservoir DPIs: Novopulmon Novolizer, Giona Easyhaler and DuoResp Spiromax, wer …
Comparative in vitro performance evaluation of the Novopulmon 200 Novolizer and Budesonid-ratiopharm Jethaler: two novel budesonide dry powder inhalers.
de Boer AH, Gjaltema D, Hagedoorn P, Frijlink HW.
de Boer AH, et al.
Pharmazie. 2004 Sep;59(9):692-9.
Pharmazie. 2004.
PMID: 15497751
A special single dose collector and a multi stage liquid impinger were used to assess the consistency of delivered dose and fine particle fraction respectively, of the Novopulmon 200 Novolizer (Viatris, Frankfurt, Germany) and Budesonid-ratiopharm Jethaler (Ratiopharm, Ulm …
A special single dose collector and a multi stage liquid impinger were used to assess the consistency of delivered dose and fine particle fr …
Item in Clipboard
Improvement of asthma therapy by a novel budesonide multidose dry powder inhaler.
Möller M, Fritsche D, Rivera D, Libertus H.
Möller M, et al.
Arzneimittelforschung. 2003;53(8):562-7. doi: 10.1055/s-0031-1297150.
Arzneimittelforschung. 2003.
PMID: 13677246
Clinical Trial.
The objective of the present post-marketing surveillance (PMS) was the evaluation of efficacy, tolerability and acceptance of the novel budesonide (CAS 51333-22-3) multidose dry powder inhaler (MDPI) Novopulmon 200 Novolizer. A total of 3,057 patients suffering from allerg …
The objective of the present post-marketing surveillance (PMS) was the evaluation of efficacy, tolerability and acceptance of the novel bude …
Item in Clipboard
A retrospective database analysis on persistence with inhaled corticosteroid therapy: comparison of two dry powder inhalers during asthma treatment in Germany.
Voshaar T, Kostev K, Rex J, Schröder-Bernhardi D, Maus J, Munzel U.
Voshaar T, et al.
Int J Clin Pharmacol Ther. 2012 Apr;50(4):257-64. doi: 10.5414/cp201665.
Int J Clin Pharmacol Ther. 2012.
PMID: 22456296
Treatment persistence of asthma patients (ICD 10 code: J45) using 200 mug budesonide either via Novopulmon/Budecort (Novolizer group = NOV) or Pulmicort (Turbuhaler group = TUR) was compared. ...
Treatment persistence of asthma patients (ICD 10 code: J45) using 200 mug budesonide either via Novopulmon/Budecort (Novolizer group …
Item in Clipboard
Cite
Cite